Machine Learning Is Enabling A New Era For Precision Medicine And Pharmacogenomics
Key takeaways
- Healthcare Machine Learning Is Enabling A New Era For Precision Medicine And Pharmacogenomics By Dr.
- Forbes contributors publish independent expert analyses and insights.
- As the authors indicate, these opportunities are already being leveraged in some of the most critical specialities, including across psychiatry, cardiology, oncology, and infectious diseases.
Healthcare Machine Learning Is Enabling A New Era For Precision Medicine And Pharmacogenomics By Dr. Sai Balasubramanian, M.D., J.D.,
Forbes contributors publish independent expert analyses and insights. Sai writes about healthcare, innovation and technology.Follow Author Jun 27, 2026, 12:35pm EDT--:-- / --:--This voice experience is generated by AI. Learn more.This voice experience is generated by AI. Learn more.Summary Medicine is rapidly evolving from statistical, evidence-based approaches to predictive, genotype-directed care, driven by advanced AI and machine learning. This shift is centered on pharmacogenomics, which leverages an individual's unique genetic makeup to predict drug responses. AI models analyze drug-gene interactions and vast genomic data, enabling customized dosing and predicting adverse reactions, revolutionizing fields like psychiatry, cardiology, and oncology with ultra-targeted therapies. Additionally, ML algorithms significantly improve early disease detection by analyzing medical imaging and patient data for conditions such as cancer and diabetes. These powerful AI models are poised to transform healthcare, offering immense value from diagnosis and drug design to patient monitoring and longevity medicine.
AI and machine learning has unlocked significant value across the entire healthcare delivery lifecycle.gettyMedicine has always operated as an “evidence based” field, meaning that it generally pursues experimentation to gather evidence to support a specific claim for diagnostic and treatment success. For example, medications often operate on the laws of statistical averages: if an overwhelming majority of people respond positively to a specific drug, then it is generally prescribed more broadly as applicable to a wider part of the population, until the evidence proves otherwise. However, this also means that a percentage of the population will be impacted by the margin of error and may experience side effects, lack of therapeutic benefit, or perhaps more harmful consequences due to ill-suited therapy.